Seroquel Sustained Release (SR)
D1444C00132
Phase 3 small_molecule completed
Quick answer
Seroquel Sustained Release (SR) for Schizophrenic Disorder is a Phase 3 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Schizophrenic Disorder
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed